A Phase II Study of Lapatinib for Brain Metastases in Su

Project: Research project

Project Details

Description

A Phase II Study of Lapatinib for Brain Metastases in Subjects with ErbB2-Positive Breast Cancer Following Trastuzumab-based Systemic Therapy and Cranial Radiotherapy
StatusFinished
Effective start/end date11/22/0511/1/09

Funding

  • GlaxoSmithKline

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.